Mimedx (MDXG) Total Debt (2011 - 2026)

Mimedx has disclosed Total Debt across 12 years of filings, most recently posting $17.6 million for Q1 2026.

• Total Debt for Q1 2026 came in at $17.6 million, down 5.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.6 million (down 5.7% YoY), and the FY2025 annual result was $18.0 million, down 4.58% from the prior year.
• Total Debt came in at $17.6 million for Q1 2026 at Mimedx, down from $18.0 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $49.1 million in Q4 2023 to a low of $17.6 million in Q1 2026.
• The 5-year median for Total Debt is $20.4 million (2024), against an average of $32.8 million.
• Across the five-year window, Total Debt rose 1.04% in 2023 and plunged 61.65% in 2024, its largest moves.
• Mimedx's Total Debt stood at $48.6 million in 2022, then rose by 1.04% to $49.1 million in 2023, then sank by 61.65% to $18.8 million in 2024, then decreased by 4.58% to $18.0 million in 2025, then fell by 2.08% to $17.6 million in 2026.
• The last three Total Debt figures came in at $17.6 million (Q1 2026), $18.0 million (Q4 2025), and $18.2 million (Q3 2025), per Business Quant data.